v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss attributable to Ordinary shareholders $ (22,516,222) $ (72,870,432)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,244,268 2,020,610
Stock based compensation 497,806 47,211,816
Deferred income taxes (14,303) (193,261)
Unrealized foreign exchange loss/(profit) (831,009) 132,121
Gain over liability settled/expense through issuance of equity shares (64,875)
Fair value losses/(profits) in financial instruments carried at fair value 3,984,386 14,844,420
Impairment of investment 269,470 1,245,326
Expected credit loss (net of reversal) 2,654,182 246,115
Assets written off 82,032
Balances written off/(back) (1,545,749) (8,143,051)
Gain on extinguishment of intercompany financial assets and liabilities (482,689)
Net loss attributable to non-controlling interest, net of tax (500,940) (192,879)
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:    
Inventories 85,980 (131,868)
Accounts receivables, net (4,776,282) 780,880
Prepayments and other assets (3,159,457) (4,822,952)
Accounts payable and accrued expenses 225,169 2,833,077
Other liabilities 3,576,831 (1,102,120)
Net cash used in operating activities (20,271,401) (18,142,198)
Cash flows from investing activities    
Purchase of property and equipment and intangible assets (1,009,660) (424,910)
Proceeds from sale of mutual fund 112,847 309,289
Net cash used in investing activities (896,813) (115,621)
Cash flows from financing activities    
Proceeds from issue of Ordinary Shares 6,519,429 7,073,913
Proceeds from issue of equity shares of subsidiary 6,645,789
Net proceeds/(payments) from borrowings 8,279,523 3,669,290
Proceeds from forward purchase agreement 1,000,000
Net cash generated from financing activities 21,444,741 11,743,203
Effect of exchange rate changes on cash and cash equivalents 3,168
Net (decrease)/increase in cash and cash equivalents (including restricted cash) 276,527 (6,511,448)
Cash acquired in business combination 1,470,453
Cash and cash equivalents at the beginning of the period (including restricted cash) 5,053,640 11,565,088
Total cash and cash equivalents 6,800,620 5,053,640
Reconciliation of cash and cash equivalents    
Cash and cash equivalents 6,578,594 4,836,576
Restricted cash 222,026 217,064
Supplemental disclosure of cash flow information    
Cash paid for interest, net of amounts capitalized 2,742,101 1,318,139
Non-cash investing and financing activities    
Consideration payable in connection with acquisitions 6,407,380 8,376,253
Interest accrued on borrowings $ 3,659,399 $ 2,123,633